Phase 1 data confirms SAB-142 does not cause serum sickness and has low/no immunogenicity at any dose and in all cohorts, ...

New research has mapped the cell types that specialize to form reproductive organs in both sexes, identifying key genes and ...

According to DataM Intelligence, the global Alternative Proteins Market was valued at USD 34.3 billion in 2024 and is projected to expand to USD 109.5 billion by 2032, growing at a robust CAGR of 15.6 ...

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today ...

Co-director Shannon Chipman knows a thing or two about Tchaikovsky’s famous Christmas ballet “The Nutcracker.” Her team ...

Seasonal affective disorder (SAD) is recognized as a recurring major depressive disorder, typically starting in the fall and ...

Biocerta Precision Diagnostics, Inc., a biotechnology company pioneering functional drug sensitivity testing (DST) to personalize cancer therapy, today announced two major business milestones: (1) an ...

It comes months after the company issued an apology for the former boss' social media posts regarding chants during Bob Vylan ...

Research shows how cells respond to brain injury by releasing corticotropin-releasing hormone, which helps to repair damage.

Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company ...

In Les Snead’s office, behind the minimalist standing desk, opposite the bookshelf filled with volumes on greatness, process ...

Aerospace engineer Michi Benthaus will become the first wheelchair user ever to reach space on Thursday (Dec. 18), and you ...